Sort
51,593 grants matching “hepatitis”
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis
$378,069Jaime C Chu · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DK
Pharmacotoxicology of Trichloroethylene Metabolites
$378,067Peter W. Stacpoole · University Of Florida · R01 · FY2009 · ES
Treatment Study Using Depot Naltrexone(3/6)NY/Bellevue Protocol Treatment Site
$378,064Joshua D Lee · New York University School Of Medicine · R01 · FY2008 · DA
Biology of the orphan receptor Rev-erbalpha
$378,017Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2008 · DK
Feeding Drives HSF1 Transcriptional Programs Required for Global Protein Synthesis
$378,001Steven E Shoelson · Joslin Diabetes Center · R01 · FY2018 · DK
Hydroxyurea Pharmacokinetics and Pharmacogenomics
$378,000Russell E Ware · St. Jude Children'S Research Hospital · R01 · FY2008 · HL
Long noncoding RNAs regulating liver fibrosis
$378,000Alan C Mullen · Massachusetts General Hospital · R01 · FY2020 · DK
Role of CMA failure in NASH progression to Hepatocellular Carcinoma
$378,000Esperanza Arias-Perez · Albert Einstein College Of Medicine · R01 · FY2022 · DK
Long noncoding RNAs regulating liver fibrosis
$378,000Alan C Mullen · Massachusetts General Hospital · R01 · FY2021 · DK
Role of CMA failure in NASH progression to Hepatocellular Carcinoma
$378,000Esperanza Arias-Perez · Albert Einstein College Of Medicine · R01 · FY2021 · DK
Role of CMA failure in NASH progression to Hepatocellular Carcinoma
$378,000Esperanza Arias-Perez · Albert Einstein College Of Medicine · R01 · FY2023 · DK
Hydroxyurea Pharmacokinetics and Pharmacogenomics
$378,000Russell E Ware · St. Jude Children'S Research Hospital · R01 · FY2009 · HL
Long noncoding RNAs regulating liver fibrosis
$378,000Alan C Mullen · Massachusetts General Hospital · R01 · FY2019 · DK
Hydroxyurea Pharmacokinetics and Pharmacogenomics
$378,000Russell E Ware · St. Jude Children'S Research Hospital · R01 · FY2010 · HL
Role of Base Excision Repair in Limiting Hepatocellular Carcinomas
$377,998R Stephen Lloyd · Oregon Health & Science University · R01 · FY2020 · ES
Role of Lipoprotein Receptors in Venous Thrombosis
$377,993Dudley K. Strickland · University Of Maryland Baltimore · R01 · FY2015 · HL
The therapeutic effect of cannabigerol (CBG) with or without cannabidiol (CBD) in diet-induced non-alcoholic fatty liver disease
$377,986Yuyan Han · University Of Northern Colorado · R15 · FY2024 · DK
TORC2-dependent regulation of gluconeogensis
$377,982Michael Dale Conkright · Scripps Florida · R01 · FY2010 · DK
Liver Dendritic Cells in Tolerance and Immunity
$377,974Ronald P Dematteo · Sloan-Kettering Inst Can Research · R01 · FY2013 · DK
Highly Sensitive HIV Viral Load Assay for Point-of-Care Settings
$377,971Waseem Asghar · Florida Atlantic University · R56 · FY2019 · AI
Training in Environmental Pathology
$377,952Agnes B Kane · Brown University · T32 · FY2010 · ES
Immunity and Virus Disease
$377,879Raymond M Welsh · Univ Of Massachusetts Med Sch Worcester · R37 · FY2008 · AI
Methadone and HIV drug interactions
$377,863University Of Washington · R01 · FY2004 · DA
Molecular Mechanisms of Rapamycin's effects on Health and longevity.
$377,843Joseph A. Baur · University Of Pennsylvania · R01 · FY2016 · AG
Targeting the NLRP3 inflammasome to limit pathologic sterile inflammation
$377,812Fayyaz S. Sutterwala · University Of Iowa · R56 · FY2015 · AI